Biocon Says Biocon Biologics Secures U.S. Market Entry For Yesafili Biosimilar
Reuters
04-15
April 15 (Reuters) - Biocon Ltd :: *BIOCON LTD - BIOCON BIOLOGICS SECURES U.S. MARKET ENTRY FOR YESAFILI BIOSIMILAR *BIOCON LTD - YESAFILI TO LAUNCH IN U.S. IN SECOND HALF OF 2026 OR EARLIER *BIOCON - BIOCON BIOLOGICS, REGENERON EXECUTED SETTLEMENT AGREEMENT TO DISMISS PENDING APPEAL